Pharmacological targeting of GSK3β confers protection against podocytopathy and proteinuria by desensitizing mitochondrial permeability transition

類似資料

• Redox-sensitive glycogen synthase kinase 3β directed control of mitochondrial permeability transition: Rheostatic regulation of acute kidney injury
  著者:: Wang, Zhen, 等
  出版事項: (2013)
• Genetic and Pharmacologic Targeting of Glycogen Synthase Kinase 3β Reinforces the Nrf2 Antioxidant Defense against Podocytopathy
  著者:: Zhou, Sijie, 等
  出版事項: (2016)
• Delayed Administration of a Single Dose of Lithium Promotes Recovery from AKI
  著者:: Bao, Hui, 等
  出版事項: (2014)
• Regulation and pharmacology of the mitochondrial permeability transition pore
  著者:: Zorov, Dmitry B., 等
  出版事項: (2009)
• Therapeutic targeting of GSK3β enhances the Nrf2 antioxidant response and confers hepatic cytoprotection in hepatitis C
  著者:: Jiang, Yongfang, 等
  出版事項: (2014)